Linden Capital To Acquire SeraCare For $4/Share

by Lisa Levin, Benzinga Editor
February 13, 2012 7:12 AM | 17 seconds read |
SeraCare Life Sciences Inc SRLS agreed to be bought by Linden Capital Partners for $4 per share. SeraCare's board had approved the terms of the deal. The offer price represents a 19% premium to the closing price of $3.37 on Friday. SRLS shares gained 6.23% to close at $3.58 on Friday.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: NewsM&Amerger and acquisition
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!